[Effect of dipyridamole on blood levels of fibroblast growth factor and vascular endothelial growth factor in patients with ischemic heart disease].
Addition if dipyridamole to standard therapy in patients with ischemic heart disease was associated with improvement of functional class of angina and elevation of blood levels of fibroblast growth factor and Vascular Endothelial Growth Factor.
Buziashvili
Iu I
IuI
Matskeplishvili
S T
ST
Asymbekova
E U
EU
Khapiĭ
I Kh
IKh
Kamardinov
D Kh
DKh
Buval'tsev
V I
VI
D000368:Aged; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005346:Fibroblast Growth Factors / Q000097:blood* / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood* / Q000188:drug therapy*; D016896:Treatment Outcome; D042442:Vascular Endothelial Growth Factors / Q000097:blood* / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D042442:Vascular Endothelial Growth Factors; D014665:Vasodilator Agents; D005346:Fibroblast Growth Factors; D004176:Dipyridamole